249 related articles for article (PubMed ID: 37445974)
1. Diagnostic and Prognostic Value of PACAP in Multiple Myeloma.
Tóth T; Alizadeh H; Polgár B; Csalódi R; Reglődi D; Tamás A
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445974
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells.
Li M; Cortez S; Nakamachi T; Batuman V; Arimura A
Cancer Res; 2006 Sep; 66(17):8796-803. PubMed ID: 16951196
[TBL] [Abstract][Full Text] [Related]
3. Decreased synovial fluid pituitary adenylate cyclase-activating polypeptide (PACAP) levels may reflect disease severity in post-traumatic knee osteoarthritis after anterior cruciate ligament injury.
Sun BY; Sun ZP; Pang ZC; Huang WT; Wu SP
Peptides; 2019 Jun; 116():22-29. PubMed ID: 31039374
[TBL] [Abstract][Full Text] [Related]
4. Intravenous infusion of pituitary adenylate cyclase-activating polypeptide (PACAP) in a patient with multiple myeloma and myeloma kidney: a case study.
Li M; Maderdrut JL; Lertora JJ; Batuman V
Peptides; 2007 Sep; 28(9):1891-5. PubMed ID: 17582655
[TBL] [Abstract][Full Text] [Related]
5. PACAP-38 and PAC1 Receptor Alterations in Plasma and Cardiac Tissue Samples of Heart Failure Patients.
Szabó D; Sárszegi Z; Polgár B; Sághy É; Reglődi D; Tóth T; Onódi Z; Leszek P; Varga ZV; Helyes Z; Kemény Á; Ferdinandy P; Tamás A
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409075
[TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stem/stromal cells suppress spinal inflammation in mice with contribution of pituitary adenylate cyclase-activating polypeptide (PACAP).
Tsumuraya T; Ohtaki H; Song D; Sato A; Watanabe J; Hiraizumi Y; Nakamachi T; Xu Z; Dohi K; Hashimoto H; Atsumi T; Shioda S
J Neuroinflammation; 2015 Feb; 12():35. PubMed ID: 25889720
[TBL] [Abstract][Full Text] [Related]
7. Examination of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) as a Potential Biomarker in Heart Failure Patients.
Sarszegi Z; Szabo D; Gaszner B; Konyi A; Reglodi D; Nemeth J; Lelesz B; Polgar B; Jungling A; Tamas A
J Mol Neurosci; 2019 Jul; 68(3):368-376. PubMed ID: 29353438
[TBL] [Abstract][Full Text] [Related]
8. Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury.
Arimura A; Li M; Batuman V
Blood; 2006 Jan; 107(2):661-8. PubMed ID: 16204306
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory Effects of the Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide in Acute
Figueiredo CA; Düsedau HP; Steffen J; Gupta N; Dunay MP; Toth GK; Reglodi D; Heimesaat MM; Dunay IR
Front Cell Infect Microbiol; 2019; 9():154. PubMed ID: 31192159
[TBL] [Abstract][Full Text] [Related]
10. The change of plasma pituitary adenylate cyclase-activating polypeptide levels after aneurysmal subarachnoid hemorrhage.
Jiang L; Wang WH; Dong XQ; Yu WH; Du Q; Yang DB; Wang H; Shen YF
Acta Neurol Scand; 2016 Aug; 134(2):131-9. PubMed ID: 26471292
[TBL] [Abstract][Full Text] [Related]
11. Examination of pituitary adenylate cyclase-activating polypeptide in Parkinson's disease focusing on correlations with motor symptoms.
Pham D; Polgar B; Toth T; Jungling A; Kovacs N; Balas I; Pal E; Szabo D; Fulop BD; Reglodi D; Szanto Z; Herczeg R; Gyenesei A; Tamas A
Geroscience; 2022 Apr; 44(2):785-803. PubMed ID: 35220508
[TBL] [Abstract][Full Text] [Related]
12. Presence of pituitary adenylate cyclase activating polypeptide-38 in human plasma and milk.
Borzsei R; Mark L; Tamas A; Bagoly T; Bay C; Csanaky K; Banki E; Kiss P; Vaczy A; Horvath G; Nemeth J; Szauer E; Helyes Z; Reglodi D
Eur J Endocrinol; 2009 Apr; 160(4):561-5. PubMed ID: 19174531
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) plays an inhibitory role against inflammation induced by chemical damage to zebrafish hair cells.
Kasica-Jarosz N; Podlasz P; Kaleczyc J
PLoS One; 2018; 13(6):e0198180. PubMed ID: 29856797
[TBL] [Abstract][Full Text] [Related]
14. The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) is Protective in Inflammation and Oxidative Stress-Induced Damage in the Kidney.
Horvath G; Opper B; Reglodi D
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591326
[TBL] [Abstract][Full Text] [Related]
15. Plasma pituitary adenylate cyclase activating polypeptide (PACAP) levels in chronic hepatitis B patients under lamivudine treatment.
Elefsiniotis IS; Ketikoglou I; Kafiri G; Pantazis KD; Moulakakis A; Mavrogiannis C
Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1209-16. PubMed ID: 14560155
[TBL] [Abstract][Full Text] [Related]
16. Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-{kappa}B in chronic pancreatitis.
Michalski CW; Selvaggi F; Bartel M; Mitkus T; Gorbachevski A; Giese T; Sebastiano PD; Giese NA; Friess H
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G50-7. PubMed ID: 17962362
[TBL] [Abstract][Full Text] [Related]
17. Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38.
Arimura A; Li M; Batuman V
Ann N Y Acad Sci; 2006 Jul; 1070():1-4. PubMed ID: 16888145
[TBL] [Abstract][Full Text] [Related]
18. Research on the mechanism of prednisone in the treatment of ITP via VIP/PACAP-mediated intestinal immune dysfunction.
Yan X; Zhang Y; Lang H; Huang Z; Chen X; He H; Zhao Q; Wang J
Eur J Med Res; 2023 Feb; 28(1):67. PubMed ID: 36750876
[TBL] [Abstract][Full Text] [Related]
19. Regulation of oxidative stress by pituitary adenylate cyclase-activating polypeptide (PACAP) mediated by PACAP receptor.
Ohtaki H; Satoh A; Nakamachi T; Yofu S; Dohi K; Mori H; Ohara K; Miyamoto K; Hashimoto H; Shintani N; Baba A; Matsunaga M; Shioda S
J Mol Neurosci; 2010 Nov; 42(3):397-403. PubMed ID: 20387010
[TBL] [Abstract][Full Text] [Related]
20. The Neuroprotective and Biomarker Potential of PACAP in Human Traumatic Brain Injury.
Toth D; Tamas A; Reglodi D
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
